Can Fite Biofarma (XTAE:CANF) FCF Yield % : -77.72 (As of May. 15, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Can Fite Biofarma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Can Fite Biofarma's Trailing 12-Month Free Cash Flow is ₪-31.20 Mil, and Market Cap is ₪40.42 Mil. Therefore, Can Fite Biofarma's FCF Yield % for today is -77.72%.

The historical rank and industry rank for Can Fite Biofarma's FCF Yield % or its related term are showing as below:

XTAE:CANF' s FCF Yield % Range Over the Past 10 Years
Min: -77.72 Med: -21.53 Max: -11.08
Current: -77.72

During the past 13 years, the highest FCF Yield % of Can Fite Biofarma was -11.08%. The lowest was -77.72%. And the median was -21.53%.

XTAE:CANF's FCF Yield % is ranked worse than
81.72% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs XTAE:CANF: -77.72

Can Fite Biofarma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Can Fite Biofarma FCF Yield % Historical Data

The historical data trend for Can Fite Biofarma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma FCF Yield % Chart

Can Fite Biofarma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-91.80

-48.42

-30.42

-58.32

-88.26

Can Fite Biofarma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Can Fite Biofarma's FCF Yield %

For the Biotechnology subindustry, Can Fite Biofarma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Can Fite Biofarma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Can Fite Biofarma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Can Fite Biofarma's FCF Yield % falls into.

Can Fite Biofarma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Can Fite Biofarma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-31.205	/	35.35584
	=	-88.26%

Can Fite Biofarma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	35.35584
	=	0.00%

Can Fite Biofarma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Can Fite Biofarma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Can Fite Biofarma (XTAE:CANF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (XTAE:CANF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

CANF:USA

Address

10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petah-Tikva, ISR, 4951778

Website

http://www.canfite.com

Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).